LAPORTE KATHLEEN

10% owner at WORLD HEART CORP · on record since Aug 8, 2008
Director at VNUS MEDICAL TECHNOLOGIES INC · on record since May 30, 2006
Director at ISTA PHARMACEUTICALS INC · on record since Jun 26, 2006
10% owner at ISTA PHARMACEUTICALS INC · on record since Jun 26, 2006
Director at ADEZA BIOMEDICAL CORP · on record since Jun 8, 2006
Director at AFFYMAX INC · on record since Dec 18, 2006
Director at eHealth, Inc. · on record since Oct 12, 2006
Director at NOVACEA INC · on record since Feb 3, 2009
Board of Director at ISTA PHARMACEUTICALS INC · on record since Sep 16, 2003
Director at Bolt Biotherapeutics, Inc. · on record since Jun 11, 2026
Director at Q32 Bio Inc. · on record since Jun 16, 2026
10% owner at VNUS MEDICAL TECHNOLOGIES INC · on record since Oct 20, 2004
10% owner at ADEZA BIOMEDICAL CORP · on record since Dec 9, 2004
Director at TRANSGENOMIC INC · on record since Aug 13, 2018
Director at CERO THERAPEUTICS HOLDINGS, INC. · on record since Oct 12, 2021
Director at 89bio, Inc. · on record since Nov 3, 2021

Insider trading activity of LAPORTE KATHLEEN

Transactions on record: 202; since Sep 16, 2003

Open-market buys: 4; $7.6M

Open-market sells: 16; $19M

Companies traded: 10; last filing Jul 21, 2026

Figures computed from official regulatory filings — .

Companies where LAPORTE KATHLEEN has traded

Q32 Bio Inc.11 tx · $64K · Jul 21, 2026
22 tx · $24K · Jun 11, 2026
40 tx · $225.8K · Jan 20, 2026
12 tx · $150K · Jan 9, 2026
13 tx · $268K · Oct 30, 2025
23 tx · $16.4M · Dec 18, 2012
5 tx · Feb 2, 2012
24 tx · $20.3T · Apr 15, 2011
39 tx · May 27, 2008
13 tx · $443.3K · Jun 8, 2006

Track record of LAPORTE KATHLEEN

Statistical track record

Free

Open-market buys: 6

Last buy: Feb 9, 2021

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of LAPORTE KATHLEEN

Co-insiders of LAPORTE KATHLEEN

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Q32 Bio Inc.	Jul 21, 2026	AwardD (derivative)	10,826	0.00 USD	—	SEC
Q32 Bio Inc.	Jun 16, 2026	AwardD (derivative)	9,810	0.00 USD	—	SEC
Bolt Biotherapeutics, Inc.	Jun 11, 2026	AwardD (derivative)	5,000	0.00 USD	—	SEC
Q32 Bio Inc.	Jan 30, 2026	AwardD (derivative)	23,272	2.75 USD	$64K	SEC
TRANSGENOMIC INC	Jan 20, 2026	Award	520	24.00 USD	$12.5K	SEC
CERO THERAPEUTICS HOLDINGS, INC.	Jan 9, 2026	AwardD (derivative)	690,900	0.00 USD	—	SEC
TRANSGENOMIC INC	Jan 6, 2026	AwardD (derivative)	1,500	0.00 USD	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,392	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,100	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,100	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,392	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,100	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,100	—	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-56,400	0.00 USD	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-25,000	0.00 USD	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-27,400	0.00 USD	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-12,500	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Q32 Bio Inc.	Jul 21, 2026	AwardD (derivative)	10,826	0.00 USD	—	SEC
Q32 Bio Inc.	Jun 16, 2026	AwardD (derivative)	9,810	0.00 USD	—	SEC
Bolt Biotherapeutics, Inc.	Jun 11, 2026	AwardD (derivative)	5,000	0.00 USD	—	SEC
Q32 Bio Inc.	Jan 30, 2026	AwardD (derivative)	23,272	2.75 USD	$64K	SEC
TRANSGENOMIC INC	Jan 20, 2026	Award	520	24.00 USD	$12.5K	SEC
CERO THERAPEUTICS HOLDINGS, INC.	Jan 9, 2026	AwardD (derivative)	690,900	0.00 USD	—	SEC
TRANSGENOMIC INC	Jan 6, 2026	AwardD (derivative)	1,500	0.00 USD	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,392	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,100	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,100	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,392	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,250	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	AwardD (derivative)	1,100	—	—	SEC
Bolt Biotherapeutics, Inc.	Dec 16, 2025	OtherD (derivative)	-1,100	—	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-56,400	0.00 USD	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-25,000	0.00 USD	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-27,400	0.00 USD	—	SEC
89bio, Inc.	Oct 30, 2025	OtherD (derivative)	-12,500	0.00 USD	—	SEC